sellWeak cluster of 510b5-1 plan
Jeff Castelli sold $254k of FOLD
Chief Development Officer at AMICUS THERAPEUTICS, INC.. 19,154 shares at an average of $13.24, traded Dec 19, 2023, filed Dec 20, 2023.
Warning score
23Value
$254k
19,154 shares
Holdings after
358,082
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +13Trade size$254k at market
- 0Share of holdings soldSold 5.1% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-23-071911, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2023 | AGrant or award Common Stock10b5-1 | +8,643 | $0.00 | $0 | 377,236 | Dec 20, 2023 |
| Dec 19, 2023 | SOpen-market sale Common Stock10b5-1 | -17,500 | $13.25 | $232k | 359,736 | Dec 20, 2023 |
| Dec 20, 2023 | SOpen-market sale Common Stock10b5-1 | -1,654 | $13.10 | $22k | 358,082 | Dec 20, 2023 |
Related signals
Other insiders at AMICUS THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | AMICUS THERAPEUTICS, INC. | Bradley L Campbell President and CEO | $323k 22,500 shares | -2% | |
| 15Weak | AMICUS THERAPEUTICS, INC. | Bradley L Campbell President and CEO | $1.1M 75,000 shares | -7% | |
| 18Weak | AMICUS THERAPEUTICS, INC. | David Michael Clark Chief People Officer | $363k 25,642 shares | -9% | |
| 17Weak | AMICUS THERAPEUTICS, INC. | David Michael Clark Chief People Officer | $282k 25,643 shares | -9% | |
| 21Weak | AMICUS THERAPEUTICS, INC. | Bradley L Campbell President and CEO | $846k 77,926 shares | -6% | |
| 16Weak | AMICUS THERAPEUTICS, INC. | Bradley L Campbell President and CEO | $146k 14,587 shares | -1% | |
| 24Weak | AMICUS THERAPEUTICS, INC. | Ellen Rosenberg Chief Legal Officer | $958k 95,621 shares | -18% | |
| 16Weak | AMICUS THERAPEUTICS, INC. | Bradley L Campbell President and CEO | $147k 14,587 shares | -1% | |
| 23Weak | AMICUS THERAPEUTICS, INC. | David Michael Clark Chief People Officer | $259k 25,643 shares | -8% | |
| 22Weak | AMICUS THERAPEUTICS, INC. | Jeff Castelli Chief Development Officer | $774k 76,158 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.